Acute renal failure is a rapid onset of renal function impairment which is potentially reversible depending on the cause and the extent of being untreated. Acute renal failure is a common condition experienced during critical illness and ICU admission. Mortality associated with ARF is high with approximately 50% patients dying. Continuous renal replacement therapy is a type of hemodialysis that was innovated by medical practitioners facing the restrictions of peritoneal dialysis and the delays in beginning intermittent hemodialysis. Need for transporting patients to dialysis unit for treatment leads to risk to the patients’ health and delaying necessary treatment. With additional advantage of having user friendly equipment, and better solute removal, CRRT has become widely adopted and appropriately suited for treatment in acute renal failure.

The purpose of this research study titled ‘Continuous Renal Replacement Therapy Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global continuous renal replacement therapy market. This report presents and analyzes the major trends prevalent in the global continuous renal replacement therapy market and the market size and forecast.

This report categorizes the global continuous renal replacement therapy market in terms of products, modality and geographical distribution. Based on product type, the global continuous renal replacement therapy market is categorized into systems and consumables. The consumables segment is further studied for filters, tubing sets and disposables. Additionally, continuous veno-venous hemodiafiltration (CVVHDF), continuous veno-venous hemodialysis (CVVHD), continuous veno-venous hemofiltration (CVVH), slow continuous ultrafiltration (SCUF), and therapeutic plasma exchange (TPE) are the dialysis modalities considered for the purpose of this study. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional analysis is presented in terms of product type, modality and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global continuous renal replacement therapy market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the continuous renal replacement therapy market. The key players profiled in this report are Asahi Kasei Corporation, Baxter International Inc., B. Braun Melsungen AG, BeLLCo S.R.L. (Medtronic PLC), Fresenius Medical Care AG & Co. KGaA, Medica SpA, Medites Pharma spol. Sro, NxStage Medical, Inc., NIPRO Corporation, SWS Hemodialysis Care Co. Ltd. and Toray Medical Co., Ltd.

Consumables currently occupy the larger revenue share in the global continuous renal replacement treatment market. Large purchase orders of consumables and disposables and regular demand for these products mainly contribute to the dominance of these products. Some of the most common consumable products in the continuous renal replacement therapy market are filters, hemofilters, absorbent materials, tubing systems, needles and others. With growing rate of hospitalization, it is anticipated that the demand for CRRT devices and consumables will rise corresponding to the incidence of acute renal failure. It is further observed that the demand for CRRT systems will be consisted through the forecast. However, the demand for these devices will be higher than the global benchmark in emerging markets of Latin America and Asia Pacific due to rapid evolution of healthcare infrastructure and increasing healthcare expenditure in the regions.

Continuous veno-venous hemofiltration currently enjoy dominance in the global continuous renal replacement therapy market. This modality operates on the same principle as slow continuous ultrafiltration (removal of excess fluid from the body); however the filter used in CVVH different (larger pore size). Such filtered fluid is thereafter replaced with suitable fluid with suitable chemistry to normal blood. This mode used convection, therefore is suitable for removing molecules of varied sizes depending on the size of filter pores. It is expected that the demand for continuous veno-venous haemodiafiltration will witness notable growth during the forecast. This CRRT modality is a combination of ultrafiltration, convection and diffusion to enable optimum replacement of fluids and solutes in the blood.

Geographically, the global continuous renal replacement therapy market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

North America comprising of country level markets of the U.S. and Canada is the largest regional market for continuous renal replacement therapy. High prevalence of acute renal diseases, greater adoption of novel filtration systems and better reimbursement system are the key growth contributors in the North America market. Greater awareness and significant prevalence of chronic diseases leading to admissions in ICU also drive the North America continuous renal replacement therapy market. On the other hand, it is expected that Asia Pacific market will witness the fastest growth on the global front. Increasing awareness in the general population and physicians, rapid rise in the number of hospitals due to evolution of healthcare infrastructure, and rising healthcare expenditure of the general patient population are expected to drive Asia Pacific continuous renal replacement therapy market.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Continuous Renal Replacement Therapy market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Continuous Renal Replacement Therapy market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Continuous Renal Replacement Therapy market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Continuous Renal Replacement Therapy market?
• Which is the largest regional market for Continuous Renal Replacement Therapy market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Continuous Renal Replacement Therapy market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Continuous Renal Replacement Therapy market worldwide?